Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Chiron announces resignation of C. William Zadel as president of Ciba Corning Diagnostics Unit.


EMERYVILLE, Calif.--(BUSINESS WIRE)--June 19, 1995--Chiron Corp. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:CHIR CHIR Chiricahua National Monument (US National Park Service) ) announced today that C. William Zadel has resigned as president of Ciba Corning Diagnostics Corp., the company's diagnostic business unit, which was acquired on January 4, 1995, as part of Chiron's strategic partnership with Ciba-Geigy Limited.

Zadel will remain president of Ciba Corning until a replacement is named; a search for his replacement has begun. Zadel will continue to represent Chiron in diagnostic industry organizations. Zadel joined Corning Corp. in 1983 and has served as Ciba Corning's president and chief executive officer since helping to form it in 1985. He is the immediate past chairman of the Health Industry Manufacturers Association.

"For the balance of the year, we look forward to Bill's continued participation in the further development of the diagnostic business which he has played an important role building, and wish him success in his future endeavors," said William J. Rutter, Ph.D., chairman of Chiron. "Our goal is to replace Bill with another highly qualified individual who will lead the combined Chiron Diagnostics and Ciba Corning business in the next important phase, that of leveraging the inherent strengths of Ciba Corning with Chiron's immunodiagnostic immunodiagnostic

pertaining to diagnosis by immune reactions.
 and bDNA probe technologies and its activities in therapeutics and vaccines."

Chiron Corp., headquartered in Emeryville, applies biotechnology and other techniques of modern biology and chemistry to develop products intended to improve the quality of life by diagnosing, preventing and treating human disease. Chiron participates in four markets: diagnostics, including immunodiagnostics, critical care diagnostics and quantitative bDNA probe tests; therapeutics for cancer and infectious disease Infectious disease

A pathological condition spread among biological species. Infectious diseases, although varied in their effects, are always associated with viruses, bacteria, fungi, protozoa, multicellular parasites and aberrant proteins known as prions.
; adult and pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children.

pe·di·at·ric
adj.
Of or relating to pediatrics.
 vaccines; and ophthalmic ophthalmic /oph·thal·mic/ (of-thal´mik) ocular (1).

oph·thal·mic
adj.
Of or relating to the eye; ocular.


Ophthalmic
Pertaining to the eye.
 instruments and devices used for the surgical correction of vision.

CONTACT: Chiron Corp., Emeryville

Larry Kurtz, 510/601-2476
COPYRIGHT 1995 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1995, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 19, 1995
Words:285
Previous Article:Dell announces K-12 educational alliance with leading software developers and regional resellers; new vice president tapped to lead Dell's education...
Next Article:NINTENDO OF AMERICA INC. EXPANDS MANAGEMENT STRENGTH.
Topics:



Related Articles
Van C. Campbell Assumes Role as Chairman Of Corning Life Sciences Inc.
PERSEPTIVE BIOSYSTEMS ANNOUNCES NEW MANAGEMENT APPOINTMENTS.
Ciba Corning achieves ISO 9000 registration at worldwide manufacturing and development sites.
Chiron Names Richard Barker President of Chiron Diagnostics.
Metra Biosystems Inc. Announces Distribution Agreement with Amersham International; Company Also Announces 510k Filing by Ciba Corning Diagnostics,...
Chiron Diagnostics and Metra Biosystems Announce FDA Clearance for Automated Bone Resorption Assay.
Premier announces agreement with Chiron.
Chiron and Gen-Probe Form Strategic Alliance to Further Improve the Safety of the World's Blood Supply.
DRUG GIANTS TO MERGE\Ciba, Sandoz to pool biotech research efforts.
Ciba specialty chemicals adds European distributors. (Contracts, Licenses).

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles